RenoFlavone™ is the fermented soy extract manufactured through RenoSorb™ technology, standardized for highly water-soluble isoflavone genistein phosphate. It can easily cross the oral absorption barrier in the human body and provide better bioavailability and maximized efficacy. Features include 100,000X aqueous solubility, 3.7X oral bioavailability, scientifically proven efficacy, a unique absorption mechanism, and recognition as a 2023 US FDA New Dietary Ingredient.

Ingredient Name: Fermented Soy Extract

Active Component: Genistein Phosphate

Functions: Supplement

Labeling Claims: Ethylene Oxide-free, GMO-free, Gluten-free, Vegan

Certifications & Compliance: FDA Compliant, GMP, Generally Recognized As Safe (GRAS), New Dietary Ingredients (NDI)

Ask Pharm-Rx Chemical Corp. Questions

Mark Bostel avatar
Message our experts with questions
Mark Bostel avatar

Mark Bostel

Please reach out to me with any questions, I am happy to assist you in finding the right product or learning more about our storefront

Enhanced TDS

Identification & Functionality

Features & Benefits

Applications & Uses


Physical Form
Soluble In
White to pale yellow fine powder
Chemical Properties
ValueUnitsTest Method / Conditions
Water-soluble Isoflavone Derivativesmin. 70%QA_Q02_AH1,HPLC
Arsenic Contentmax. 2ppmMOHWH0014.03
Physical Properties
ValueUnitsTest Method / Conditions
Loss on Dryingmax. 6%QA-Q01-AH1
Microbiological Values
ValueUnitsTest Method / Conditions
Yeast & Molds Countmax. 102cfu/gMOHWM0008.01
Total Aerobic Plate Countmax. 103cfu/gMOHWM0014.01
Escherichia ColiNegative/gMOHWM0023.02
Enterobacteriamax. 10cfu/gMOHWM0028.00
Heavy Metals
ValueUnitsTest Method / Conditions
Lead Contentmax. 20ppmMOHWH0014.03

Regulatory & Compliance

Certifications & Compliance
FDA Disclaimer

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Technical Details & Test Data

Pharmacokinetic Profile

RenoFlavone™ - Pharmacokinetic Profile - 1
Mean plasma concentration-time profiles of genistein in rats after oral adminstration of native genistein and RenoFlavone™ at 3.7 u mol/kg bw. Data are mean  SE (n = 4).

Animal Study Improve Menopausal Bone Health

RenoFlavone™ - Animal Study Improve Menopausal Bone Health - 1
RenoFlavone™ - Animal Study Improve Menopausal Bone Health - 1
Osteoprotective effect of RenoFlavone™, a derivative of genistein with high bioavailability, in ovariectomized rats. Mi ovarietomized rats. Bet of plate and entral met wip (15.2 umol/kg bw/day) after 12-week treatment. Data are mean ‡SD, n = 6. Value are mean‡SEM. ** p < 0.01. RenoFlavone™ vs placebo group (paired t-test).

Human study Relieve menstrual discomfort

RenoFlavone™ - Human study Relieve menstrual discomfort - 1
A randomized controlled trial of RenoFlavone™ in the treatment of primary dysmenorrhea. Effects of RenoFlavone™ (20 mg/ day) and placebo on menstrual pain score (Short form McGill pain questionnaire score, SF-MPQ) in first month (The trial is ongoing). Value are mean  SEM, n = 40. Comparison of changes between the study groups (chi-square test). Significance of double star symbol is *** p< 0.001.

Packaging & Availability

Packaging Type

Storage & Handling

Shelf Life
3 years
Storage and Shelf Life Conditions

Store in aluminum bag at controlled room temperature for 3 years.